The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.


Updates from The Motley Fool

Latest updates on Abiomed from Fool.com.  The Fool has written over 100 articles on Abiomed.


Stock Performance

View Interactive ABMD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Abiomed.
Current Price: $112.94
Prev Close: $109.95
Open: $109.62
Bid: $99.00
Ask: $137.00
Day's Range: $109.53 - $114.68
52wk Range: $67.80 - $132.95
Volume: 628,687
Avg Vol 761,853
Market Cap: $5B
P/E (ttm): 113.35
EPS (ttm): $0.97
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Abiomed.
CAPS Rating 4 out of 5
 
167 Outperform
33 Underperform
CAPS All Stars
 
30 Outperform
10 Underperform

How do you think Abiomed will perform against the market?



You pick for Abiomed is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael R. Minogue, CEO

79% Approve

Based on 29 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Abiomed.

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT